Virginia Economic Review

Recent major biopharmaceutical announcements have sent a clear signal from the industry: Virginia is the future of biopharma manufacturing.

Food and beverage and pharmaceutical companies rely on Virginia’s cold chain infrastructure to succeed.

States, nations, and any municipality can build and tout their critical infrastructure that, on the surface, may appear second to none. Think: thriving, automated food and agriculture ecosystems. Sprawling office buildings outfitted with remote smart sensors. Unflappable financial markets.